The KIF7 Monoclonal Antibody is a targeted immunological reagent designed to detect and study the kinesin family member 7 (KIF7) protein. KIF7 is a microtubule-associated motor protein critical for Hedgehog (Hh) signaling, ciliary trafficking, and cellular proliferation. This antibody is primarily used in immunohistochemistry (IHC), Western blot (WB), and related assays to explore KIF7’s role in developmental biology, ciliopathies, and cancer research.
Specificity: Targets a conserved epitope in KIF7, enabling cross-reactivity across human, mouse, and rat tissues.
Storage: Store at -20°C or 4°C for short-term use. Repeated freeze-thaw cycles should be avoided.
Concentration: Typically provided in PBS with 50% glycerol and 0.5% BSA to stabilize the antibody .
Application | Dilution | Fixation |
---|---|---|
IHC | 1:200 | PFA (freshly prepared) |
Tissue Suitability: Effective in detecting KIF7 in lung, ovary, and kidney tissues. Customer validations confirm strong staining in paraffin-embedded sections .
Hedgehog Signaling: Studies using this antibody have shown KIF7’s role in regulating Hh pathway components (e.g., GLI1, GLI2) in respiratory epithelial cells and fibroblasts .
Ciliary Trafficking: KIF7 localizes to the cilium tip in response to Hh signaling, modulating Gli transcription factor activity. Mutations in KIF7 disrupt ciliary architecture and Hh signaling, leading to hyperproliferation in respiratory tissues .
Cerebral Cortex Development: KIF7 depletion in mice causes cortical layering defects and axonal pathfinding errors, implicating its role in neuronal migration and connectivity .
Multiple KIF7 antibodies exist, differing in host, clonality, and applications:
The Boster Bio A04321 monoclonal antibody is unique in its cross-reactivity with rat tissues and validated IHC performance.
Rabbit polyclonal antibodies (e.g., Proteintech, Bio-Techne) offer broader applications (WB, IP) but lack cross-species reactivity .
Hh-Induced Trafficking: KIF7 accumulates at the cilium tip upon Hh stimulation, facilitating Gli protein activation. Mutants lacking microtubule-binding ability still localize to the tip, suggesting IFT-dependent transport mechanisms .
Pathological Relevance: Dysregulation of KIF7 contributes to ciliopathies (e.g., respiratory defects) and cancer (e.g., lung, glioblastoma) .
KIF7 plays a crucial role in regulating hedgehog signaling, acting as both a positive and negative regulator of the sonic hedgehog (Shh) and Indian hedgehog (Ihh) pathways. Functioning downstream of SMO, KIF7 exerts its effects through both SUFU-dependent and -independent mechanisms. Its involvement extends to the regulation of microtubule dynamics, the organization of the ciliary tip, and control of ciliary localization of SUFU-GLI2 complexes. KIF7 is essential for GLI3 localization to cilia in response to Shh. It negatively regulates Shh signaling by preventing inappropriate GLI2 activation (the transcriptional activator) in the absence of ligand. Conversely, it positively regulates Shh signaling by preventing the processing of GLI3 into its repressor form. In keratinocytes, KIF7 promotes the dissociation of SUFU-GLI2 complexes, leading to GLI2 nuclear translocation and Shh signaling activation. Its regulatory functions are also involved in epidermal differentiation and chondrocyte development.
KIF7 is a kinesin motor protein that functions as a critical regulator of the Hedgehog (Hh) signaling pathway. It plays dual roles as both a negative and positive regulator of sonic hedgehog (Shh) and Indian hedgehog (Ihh) pathways, acting downstream of the Smoothened (SMO) receptor through both Suppressor of Fused (SUFU)-dependent and -independent mechanisms . KIF7 is essential for:
Proper organization of the ciliary tip
Control of ciliary localization of SUFU-GLI2 complexes
Localization of GLI3 to cilia in response to Shh
Regulation of microtubular dynamics
Prevention of inappropriate activation of transcriptional activator GLI2 in the absence of ligand
Prevention of the processing of GLI3 into its repressor form
The importance of KIF7 is underscored by the serious developmental consequences associated with its mutation, including Acrocallosal Syndrome, Joubert Syndrome, and intellectual disability with corpus callosum dysgenesis .
KIF7 monoclonal antibodies have been validated for multiple research applications, providing reliable detection of endogenous KIF7 proteins. Based on available information, these antibodies are suitable for:
Each application requires optimization of antibody concentration, incubation times, and detection methods for specific experimental conditions .
KIF7 serves as a bifunctional regulator of the Hedgehog signaling pathway, with distinct actions depending on pathway activation status:
In the absence of Hedgehog signaling:
KIF7 and suppressor of fused (SUFU) restrain Gli transcription factors in the cytosol
KIF7 promotes Gli3 processing into its transcriptional repressor form
KIF7 prevents inappropriate activation of the transcriptional activator GLI2
In the presence of Hedgehog signaling:
KIF7, SUFU, and Gli transcription factors are enriched at the tip of cilium
KIF7 is required for localization of GLI3 to cilia in response to Shh
KIF7 prevents the processing of the transcription factor GLI3 into its repressor form
In keratinocytes, KIF7 promotes the dissociation of SUFU-GLI2 complexes, GLI2 nuclear translocation and Shh signaling activation
This dual regulatory function makes KIF7 a critical control point in Hedgehog signaling, with significant implications for development and disease processes.
To maintain optimal antibody performance, researchers should follow these storage guidelines for KIF7 monoclonal antibodies:
Long-term storage: Store at -20°C for up to one year
Short-term storage: For frequent use, store at 4°C for up to one month
Avoid repeated freeze-thaw cycles as they can degrade antibody quality and performance
Most commercial KIF7 antibodies are supplied in a stabilized liquid form containing preservatives such as 50% glycerol, 0.5% BSA, and 0.02% sodium azide
Proper aliquoting upon first thaw is recommended to minimize freeze-thaw cycles and maintain antibody integrity throughout the research project.
Research has revealed complex relationships between KIF7's microtubule binding properties and its ciliary localization that should be considered when designing experiments:
Key findings on microtubule binding and ciliary localization:
KIF7's microtubule binding is dispensable for its Hedgehog-induced increase in ciliary localization
The KIF7 noMT variant (deficient in microtubule binding) can still localize to the cilium tip in response to Hedgehog stimulation (51.4% of SAG-treated cells vs. 14.1% of unstimulated cells)
KIF7 rigor variant (enhanced microtubule binding) shows increased ciliary tip localization even without Hedgehog stimulation (68.3% of unstimulated cells)
Motile KIF7 variants (KIF7 motile_21A and KIF7 motile_5C) demonstrated strong localization to the primary cilium tip without Hedgehog stimulation
Experimental design implications:
When studying Hedgehog pathway activation, researchers should consider that KIF7 localization may be regulated by mechanisms beyond simple microtubule binding
IFT (intraflagellar transport) appears to be the primary mechanism for Hedgehog-induced localization of KIF7 to the cilium tip
When using KIF7 mutants, researchers should carefully characterize their microtubule binding properties and ciliary localization patterns
Experiments investigating KIF7 function should include appropriate controls for both microtubule binding and Hedgehog pathway activation status
This understanding is critical for interpreting results in studies examining ciliary trafficking, Hedgehog signaling, and KIF7 function.
When working with complex tissue samples, researchers should consider several factors to ensure reliable and specific detection of KIF7:
Tissue-specific expression patterns:
KIF7 expression varies across tissues, with notable presence in developing neural tissues, lung tissues, and T-cell populations
For developmental studies, temporal expression patterns must be considered, as KIF7 plays crucial roles in tissue patterning and proliferation control
Potential cross-reactivity considerations:
KIF7 belongs to the kinesin family, which includes structurally similar motor proteins
Validate antibody specificity using appropriate controls:
KIF7 knockout/knockdown tissues
Competitive blocking with immunizing peptide
Comparison with alternative KIF7 antibody clones
Optimized tissue preparation for KIF7 detection:
Fixation methods significantly impact epitope accessibility
Antigen retrieval techniques may be necessary (particularly for formalin-fixed tissues)
Permeabilization conditions should be optimized for nuclear vs. cytoplasmic detection
For lung tissue specifically, researchers have observed that KIF7 depletion leads to increased cellular density and altered differentiation of respiratory epithelium , suggesting careful consideration of developmental stage when studying KIF7 in this context.
Several methodological approaches can be employed to study KIF7 mutations and their effects on Hedgehog signaling:
Cellular models for studying KIF7 mutations:
MEF systems: Mouse embryonic fibroblasts from KIF7 knockout mice provide a valuable system for structure-function studies
Patient-derived cells: For clinical mutations, cells derived from patients with KIF7 mutations offer insights into pathophysiology
Molecular approaches for analyzing signaling alterations:
Quantitative RT-PCR: Measure expression of Hedgehog target genes such as Ptch1
Immunofluorescence analysis: Assess ciliary localization of Gli proteins
Nuclear fractionation and Western blot: Evaluate nuclear translocation of Gli transcription factors
Functional readouts:
Cell proliferation assays (KIF7 mutants show altered growth properties)
Cyclin D1 expression analysis (increased in KIF7-depleted cells)
Assessment of microtubule stability markers (acetylated alpha tubulin and detyrosinated alpha tubulin)
These approaches enable comprehensive analysis of how specific KIF7 mutations impact Hedgehog pathway regulation and downstream cellular processes.
Detecting KIF7 by Western blot presents several technical challenges due to its size, expression level, and biochemical properties:
Common challenges:
High molecular weight: KIF7 has a calculated molecular weight of approximately 150.6 kDa, which can make transfer efficiency problematic
Variable expression levels: Endogenous KIF7 may be expressed at low levels in some cell types
Protein degradation: As a large protein, KIF7 may be susceptible to proteolytic degradation during sample preparation
Post-translational modifications: Phosphorylation or other modifications may affect antibody recognition
Optimized Western blot protocol for KIF7 detection:
Protocol Step | Recommended Conditions | Rationale |
---|---|---|
Sample preparation | Use RIPA buffer with protease inhibitor cocktail and phosphatase inhibitors | Preserves protein integrity and modification state |
Protein amount | Load 30-50 μg total protein per lane | Ensures adequate signal for detection |
Gel concentration | 6-8% SDS-PAGE or gradient gels (4-12%) | Better separation of high-molecular-weight proteins |
Transfer method | Wet transfer at low voltage (30V) overnight at 4°C | Improves transfer efficiency of large proteins |
Blocking | 5% non-fat dry milk or BSA in TBST for 1 hour | Reduces background without interfering with antibody binding |
Primary antibody | Dilute 1:500-1:2000, incubate overnight at 4°C | Optimizes signal-to-noise ratio |
Washing | 4-5 times × 5 minutes with TBST | Removes unbound antibody |
Secondary antibody | HRP-conjugated anti-mouse IgG, 1:5000 | Compatible with most detection methods |
Detection method | Enhanced chemiluminescence (ECL) | Provides sensitive detection |
Validation approaches:
Include KIF7-depleted or knockout samples as negative controls
Consider using recombinant KIF7 protein as a positive control
Verify results with multiple antibody clones when possible
This optimized protocol addresses the technical challenges associated with KIF7 detection by Western blot, enhancing reliability and reproducibility of results.
KIF7 has distinct functions in ciliated versus non-ciliated cells, which has important implications for experimental design:
Functions in ciliated cells:
Regulates Hedgehog signaling through control of ciliary trafficking
Organizes the cilium tip and influences cilium length
Controls ciliary localization of SUFU-GLI complexes
Functions in non-ciliated cells:
May regulate microtubule dynamics in the cytoplasm
Influences cell cycle progression and proliferation
Affects T-cell development independently of canonical ciliary functions
Experimental design considerations:
Cell Type | Key Considerations | Suggested Approaches |
---|---|---|
Ciliated cells (e.g., MEFs, respiratory epithelium) | Ciliary morphology may influence interpretations | Include ciliary markers (acetylated tubulin) in immunofluorescence studies |
Ciliary content vs. cytoplasmic content | Use cellular fractionation to separate compartments | |
Cell cycle stage affects ciliation | Synchronize cells when possible | |
Non-ciliated cells (e.g., T-cells) | Non-canonical KIF7 functions predominate | Focus on cytoskeletal dynamics, proliferation assays |
May involve different interaction partners | Consider co-immunoprecipitation studies to identify cell-type-specific interactors |
Critical experimental controls:
Cell type-appropriate positive controls for KIF7 function
Confirmation of ciliary status in experimental cells
Assessment of Hedgehog pathway responsiveness in the model system
The distinct functions of KIF7 in different cellular contexts necessitate careful experimental design and interpretation, especially when comparing results across cell types or when studying novel KIF7 functions.